Company Overview of Burrill Life Sciences Capital Fund III, L.P.
Burrill Life Sciences Capital Fund III, L.P. specializes in seed, early stage, late stage, and mezzanine investments. It prefers to invest in biotechnology, life sciences, pharmaceuticals, diagnostics, devices, human healthcare, wellness and nutraceuticals, agbio, and industrial biotechnology sectors. The fund invests globally. It invests between $1 million and $20 million on an average in its portfolio companies.
One Embarcadero Center
San Francisco, CA 94111
Founded in 2005
Key Executives for Burrill Life Sciences Capital Fund III, L.P.
Similar Private Companies By Industry
|EdgePoint Capital Advisors, LLC||United States|
|Cohane Rafferty Securities L.L.C.||United States|
|Premier Asset Collateralized Entity LLC||United States|
|Clement Corp||United States|
|WestMountain Distressed Debt, Inc.||United States|
Recent Private Companies Transactions
December 30, 2014
|Neos Therapeutics Inc.|
To contact Burrill Life Sciences Capital Fund III, L.P., please visit venture.burrillandco.com/funds-23-Burrill_Life_Sciences_Capital_Fund_III_LP__Active.html. Company data is provided by Capital IQ. Please use this form to report any data issues.